ASC-69
PD-1/PD-L1-IN-29 intermediate-2
Zeluvalimab
Reozalimab
Rosnilimab
Sudubrilimab
Erfonrilimab
Opucolimab
Prolgolimab
Rulonilimab
Cosibelimab
Sasanlimab
Pimivalimab
Peresolimab
Pucotenlimab
Retifanlimab
Pacmilimab
Emfizatamab
Geptanolimab
Gilvetmab